Tag: surface plasmon resonance market insights

Uncover key drivers, emerging technologies, and competitive movements shaping the tumor marker testing market from 2026–2035 with trusted insights from The Business Research Company

What growth pattern is forecast for the Tumor Marker Testing Market size between 2026 and 2035?

The tumor marker testing market size has seen robust expansion in recent years. It is anticipated to grow from $18.6 billion in 2025 to $20.12 billion in 2026, at a compound annual growth rate (CAGR) of 8.2%. The upward trend observed in the historic period stems from escalating cancer incidence rates, the broadened application of laboratory diagnostics in oncology, the enlargement of hospital-based cancer testing facilities, the widespread availability of established biochemical markers, and the development of extensive diagnostic laboratory networks.

The tumor marker testing market is projected to experience substantial growth over the coming years. By 2030, this market is anticipated to reach $27.23 billion, expanding at a compound annual growth rate (CAGR) of 7.9%. This projected growth is driven by factors such as increasing demand for early cancer detection, a greater adoption of precision oncology methods, the expansion of companion diagnostics, the rising application of biomarkers in selecting therapies, and continuous advancements in cancer biomarker research. Key developments expected during this period involve a growing embrace of multiplex tumor marker panels, increased reliance on blood-based cancer diagnostics, enhanced integration of tumor markers into treatment monitoring, an expansion of early cancer screening initiatives, and a stronger emphasis on personalized oncology care.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20668&type=smp

Which Drivers Are Impacting Market Performance In The Tumor Marker Testing Market?

The rising incidence of cancer is anticipated to fuel the expansion of the tumor marker testing market in the future. Cancer is defined by the uncontrolled proliferation of anomalous cells within the body. Such cells have the capacity to penetrate adjacent tissues and metastasize to different bodily regions via the circulatory and lymphatic systems. An uptick in cancer diagnoses is observed, attributed to elements like an aging global demographic, heightened exposure to environmental hazards, shifts in lifestyle, and advancements in diagnostic and detection methods. Employed for various cancers, tumor marker testing aids in diagnosis, evaluates treatment efficacy, and identifies recurrence through the measurement of distinct substances generated by cancerous cells. As an illustration, the National Health Service, a UK government body, reported in October 2025 that 2023 saw 354,820 new cancer diagnoses, averaging 972 daily, which signifies an increase of 8,605 compared to 2022. Consequently, the expanding occurrence of cancer is a key driver for the growth within the tumor marker testing market.

Which Segments Are Contributing To The Growth Of The Tumor Marker Testing Market?

The tumor marker testing market covered in this report is segmented –

1) By Product: Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines

2) By Methods: Screening, Imaging, Theranostics, Other Methods

3) By Application: Hospitals, Commercial Or Private Laboratories, Physician Offices Or Group Practices, Cancer Clinics, Ambulatory Care Centers

Subsegments:

1) By Biochemical Markers: Alpha-fetoprotein (AFP), Prostate-Specific Antigen (PSA), Carcinoembryonic Antigen (CEA), Cancer Antigen 125 (CA 125), Cancer Antigen 19-9 (CA 19-9), Human Chorionic Gonadotropin (hCG)

2) By Oncogenes: HER2 Or neu, KRAS, BRAF, EGFR (Epidermal Growth Factor Receptor), c-MYC, p53

3) By Growth Factors: Vascular Endothelial Growth Factor (VEGF), Platelet-Derived Growth Factor (PDGF), Transforming Growth Factor-beta (TGF-ß), Fibroblast Growth Factor (FGF), Insulin-like Growth Factor (IGF)

4) By Hormones: Estrogen Receptors (ER), Progesterone Receptors (PR), Thyroglobulin, Calcitonin, Adrenocorticotropic Hormone (ACTH), Gastrin

5) By Colony Stimulating Factors: Granulocyte Colony-Stimulating Factor (G-CSF), Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF), Macrophage Colony-Stimulating Factor (M-CSF)

6) By Lymphokines: Interleukin-2 (IL-2), Interferon-gamma (IFN-?), Tumor Necrosis Factor-alpha (TNF-a), Interleukin-6 (IL-6)

What Trends Are Projected To Support The Growth Of The Tumor Marker Testing Market?

Leading companies active in the tumor marker testing market are increasingly concentrating on developing advanced tests, such as molecular testing solutions, to secure a competitive advantage. These molecular testing solutions are sophisticated diagnostic approaches that examine genetic material (DNA or RNA) to identify mutations, pathogens, or particular biomarkers at a molecular level. For instance, in April 2024, RGCC International GmbH, a Switzerland-based firm focused on personalized cancer treatment, released Onco-D-clare, a pioneering cancer detection test. This innovative test empowers individuals to detect cancer before symptoms manifest by employing a combination of molecular biology and artificial neural networks. Onco-D-clare functions by isolating peripheral blood mononuclear cells from blood samples and subsequently performing a thorough gene expression analysis across more than 90 genes.

Who Are The Top-Performing Companies In The Tumor Marker Testing Market In Recent Years?

Major companies operating in the tumor marker testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche AG, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company (BD), Quest Diagnostics Inc., Agilent Technologies Inc, Hologic Inc., Illumina Inc., bioMérieux SA, Bio-Rad Laboratories Inc., Qiagen N.V., DiaSorin S.p.A., Myriad Genetics, Ortho Clinical Diagnostics PLC, Veracyte Inc., Biodesix Inc., Biocept Inc., Proteomedix AG, OncoCyte Corporation, Biocartis NV

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/tumor-marker-testing-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Tumor Marker Testing Market?

North America was the largest region in the tumor marker testing market in 2025. The regions covered in the tumor marker testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Tumor Marker Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20668&type=smp

Browse Through More Reports Similar to the Global Tumor Marker Testing Market 2026, By The Business Research Company

Tumor Infiltrating Lymphocytes Market Report 2026

https://www.thebusinessresearchcompany.com/report/tumor-infiltrating-lymphocytes-global-market-report

Circulating Tumor Cells Market Report 2026

https://www.thebusinessresearchcompany.com/report/circulating-tumor-cells-global-market-report

Tumor Necrosis Factor Inhibitor Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/tumor-necrosis-factor-inhibitor-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the surface plasmon resonance market from 2026–2035 with trusted insights from The Business Research Company

What is the expected shift in the Surface Plasmon Resonance Market’s size between 2026 and 2030?

The surface plasmon resonance market has seen rapid expansion in recent years. It is forecast to increase from $1.33 billion in 2025 to $1.49 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.8%. This growth observed historically is due to the expansion of pharmaceutical and biotech research activities, the increased application of biomolecular interaction studies, growth in academic life science research, a rising demand for analytical precision tools, and the availability of advanced optical sensing technologies.

The surface plasmon resonance market is projected to experience substantial expansion over the upcoming years. This market is set to reach $2.3 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.5%. Key drivers for this projected growth include escalating investment in the development of biologics and biosimilars, a heightened need for high-throughput screening instruments, the broadening scope of personalized medicine research, wider acceptance of biosensors in diagnostic applications, and an increased emphasis on real-time molecular analytics. Significant trends anticipated during the forecast period encompass the increasing use of high-sensitivity SPR imaging systems, a growing need for label-free biomolecular analysis, greater incorporation of SPR technology into drug discovery processes, the proliferation of portable and multi-channel SPR sensors, and a heightened focus on analyzing interactions in real-time.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20655&type=smp

Which Drivers Are Shaping Strategic Decisions In The Surface Plasmon Resonance Market?

The future expansion of the surface plasmon resonance market is anticipated to be fueled by the growing embrace of personalized medicine. This medical approach involves customizing healthcare strategies, including treatments and prevention, based on an individual’s unique genetic makeup, environmental influences, and lifestyle choices. Its increasing prevalence stems from progress in genomics, the development of targeted therapies, and a rising need for more accurate and potent medical solutions. Surface plasmon resonance contributes to personalized medicine through its capacity for real-time analysis of biomolecular interactions, facilitating the identification of specific biomarkers and the optimization of drug treatments for individual patients. As an illustration, the Personalized Medicine Coalition, a US-based hospital and health care entity, reported in February 2024 that the FDA sanctioned 16 novel personalized treatments for rare disease patients in 2023, marking an increase from 6 approvals in 2022. Among these new personalized treatments approved in 2023 were also seven drugs for cancer and three for various other diseases and conditions. Consequently, the expanding implementation of personalized medicine is a key catalyst for the growth of the surface plasmon resonance market.

What Segment Categories Are Covered In The Surface Plasmon Resonance Market?

The surface plasmon resonance market covered in this report is segmented –

1) By Product Type: Imaging System, Sensor System, Reagents

2) By Technology: Prism-Based Surface Plasmon Resonance (SPR), Grating-Based Surface Plasmon Resonance (SPR), Other Technologies

3) By Application: Drug Discovery, Drug Formulation, Controlled Drug Release, Drug Cell Interaction, Material Science, Biosensors

4) By End-User: Academic And Research Institutes, Food And Beverage Industry, Biopharmaceutical Companies, Contract Research Organizations (CROs), Other End-Users

Subsegments:

1) By Imaging System: 2D Imaging Systems, 3D Imaging Systems, High-Resolution Imaging Systems

2) By Sensor System: Optical Sensor Systems, Portable Sensor Systems, Multi-channel Sensor Systems

3) By Reagents: Binding Reagents, Sample Preparation Reagents, Stabilizing Reagents

Which Trends Are Influencing The Performance And Direction Of The Surface Plasmon Resonance Market?

Leading firms within the surface plasmon resonance market are concentrating efforts on creating sophisticated biomolecular analysis technologies, including high-throughput SPR biosensor platforms, to secure a competitive edge. This technique, SPR, leverages an optical phenomenon occurring at metal–dielectric interfaces for real-time detection of binding events, eliminating the need for labels. As an illustration, Carterra, a US-based biotechnology instrumentation company, unveiled its high-throughput SPR platform, the LSA^XT, in February 2023. This new offering provides enhanced sensitivity, significantly boosted sample throughput, and lowered sample consumption, facilitating the effective screening of membrane proteins, small molecules, and kinetic interactions. These advanced, sensitive, and high-throughput SPR systems empower pharmaceutical and biotech organizations to expedite drug discovery processes and biologics characterization. Nevertheless, this evolution simultaneously places greater demands on instrument suppliers to guarantee reproducibility and handle expanded data volumes.

Which Major Industry Participants Are Leading The Surface Plasmon Resonance Market Growth?

Major companies operating in the surface plasmon resonance market are GE HealthCare Technologies Inc., Sartorius AG, Cytiva, Bio-Rad Laboratories Inc., Bruker Corporation, HORIBA Ltd., Quanterix Corporation, Jubilant Biosys Limited, Quantum Design Inc., Reichert Inc., NanoSPR Devices, Creative BioMart Inc., Biocompare, Carterra Inc., NICOYA AB, Biosensing Instrument Inc., Plexera LLC, Insplorion AB, BioNavis Ltd., Affinité Instruments, IBIS Technologies B.V.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/surface-plasmon-resonance-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Surface Plasmon Resonance Market?

North America was the largest region in the surface plasmon resonance market in 2025. The regions covered in the surface plasmon resonance market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Surface Plasmon Resonance Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20655&type=smp

Browse Through More Reports Similar to the Global Surface Plasmon Resonance Market 2026, By The Business Research Company

Artificial Intelligence In Magnetic Resonance Imaging Mri Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-magnetic-resonance-imaging-mri-global-market-report

Magnetic Resonance Imaging Systems Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/magnetic-resonance-imaging-systems-devices-and-equipment-global-market-report

Magnetic Resonance Imaging Coils Market Report 2026

https://www.thebusinessresearchcompany.com/report/magnetic-resonance-imaging-coils-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Factors Are Propelling the Market Growth of theSurface Plasmon Resonance Market from 2025 to 2034?

The expansion of the surface plasmon resonance market is anticipated to be fueled by the rising adoption of personalized medicine. Personalized medicine, which is healthcare specifically tailored using a person’s genetic, environmental and lifestyle factors, is being adopted more widely due to advancements in genomics, a surge in targeted therapies, and the need for more precise and effective treatments. Surface plasmon resonance plays a significant role in personalized medicine by allowing for the real-time study of biomolecular interactions, the identification of specific biomarkers, and the optimization of drug therapies personalized to the patient. For example, in February 2024, the Personalized Medicine Coalition, an organization based in the US focused on healthcare and hospitals, reported that in 2023, there were 16 new FDA-approved personalized treatments for rare diseases, a significant increase from the six approved in 2022. Additionally, the personalized treatments approved in 2023 incorporated seven cancer drugs and three for other diseases and conditions. As such, the rise in the adoption of personalized medicine is directly contributing to the growth of the surface plasmon resonance market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20655&type=smp

#How Does the ProjectedSurface Plasmon Resonance Market Growth Compare Over the Forecast Period?

The size of the surface plasmon resonance market has experienced fast growth lately. The expected increase will see it rise from $1.19 billion in 2024 to $1.33 billion in 2025, showing a compound annual growth rate (CAGR) of 12.0%. The historic period’s growth is linked to progress in biotechnology, a growing demand for the discovery and development of drugs, an increase in its use in clinical diagnostics, a raised focus on protein interaction studies and an increase in academic research funding.

In the coming years, the surface plasmon resonance market is anticipated to witness accelerated growth. The projection suggests that the market will reach $2.07 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 11.6%. This considerable growth during the forecasted period can be credited to several factors such as a surge in the requirement for personalized medicine, the escalating use in food safety testing, an increased emphasis on biomarker discovery, a broadening application in environmental monitoring, and higher implementation in the agricultural biotechnology field. Key trends during this forecast period encompass the need for label-free detection technologies, the application of personalized medicine, advancements in the field of nanotechnology, the creation of compact and portable SPR systems, and the incorporation of artificial intelligence in data analysis.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20655

How Are Market Trends and Innovations Revolutionizing theSurface Plasmon Resonance Industry in Recent Times?

Key players in the surface plasmon resonance market are introducing progressive biomolecular analysis techniques, such as injection technology, to phase out the requirement for numerous dilution series. Injection technology enhances biomolecular interaction analysis by integrating sample dilution and injection into a singular action, thereby speeding up data collection in surface plasmon resonance (SPR) through quick, one-time injection kinetics and affinity measurements. For instance, in April 2022, Germany’s pharmaceutical and laboratory equipment enterprise, Sartorius AG, introduced the Octet SF3. This is an evolved surface plasmon resonance device that’s perfect for high-throughput, label-free biomolecular interaction analysis. It’s suited to both regular and infrequent users, given its durable, easy to maintain design. The inventive OneStep and NeXtStep Gradient Injection technologies result in quicker, superior quality kinetics and affinity data gathering, hugely surpassing conventional methods. It was developed in response to the expanding global need for antibody fragment characterization, vaccine research, and biologics discovery.

Which Key Market Players Are Shaping the Future and Growth of theSurface Plasmon Resonance Market?

Major companies operating in the surface plasmon resonance market are GE HealthCare Technologies Inc., Sartorius AG, Cytiva, Bio-Rad Laboratories Inc., Bruker Corporation, HORIBA Ltd., Quanterix Corporation, Jubilant Biosys Limited, Quantum Design Inc., Reichert Inc., NanoSPR Devices, Creative BioMart Inc., Biocompare, Carterra Inc., NICOYA AB, Biosensing Instrument Inc., Plexera LLC, Insplorion AB, BioNavis Ltd., Affinité Instruments, IBIS Technologies B.V., Bioptix Inc

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/surface-plasmon-resonance-global-market-report

What Are the Core Segments of the Surface Plasmon Resonance Market, and How Do They Contribute to Growth?

The surface plasmon resonance market covered in this report is segmented –

1) By Product Type: Imaging System, Sensor System, Reagents

2) By Technology: Prism-Based Surface Plasmon Resonance (SPR), Grating-Based Surface Plasmon Resonance (SPR), Other Technologies

3) By Application: Drug Discovery, Drug Formulation, Controlled Drug Release, Drug Cell Interaction, Material Science, Biosensors

4) By End-User: Academic And Research Institutes, Food And Beverage Industry, Biopharmaceutical Companies, Contract Research Organizations (CROs), Other End-Users

Subsegments:

1) By Imaging System: 2D Imaging Systems, 3D Imaging Systems, High-Resolution Imaging Systems

2) By Sensor System: Optical Sensor Systems, Portable Sensor Systems, Multi-channel Sensor Systems

3) By Reagents: Binding Reagents, Sample Preparation Reagents, Stabilizing Reagents

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=20655&type=smp

What Regions Are Dominating the Surface Plasmon Resonance Market Growth?

North America was the largest region in the surface plasmon resonance market in 2024. The regions covered in the surface plasmon resonance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Surface Plasmon Resonance Market 2025, By The Business Research Company:

Magnetic Resonance Imaging Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/magnetic-resonance-imaging-devices-and-equipment-global-market-report

Magnetic Resonance Imaging Systems Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/magnetic-resonance-imaging-systems-devices-and-equipment-global-market-report

Magnetic Resonance Imaging Coils Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/magnetic-resonance-imaging-coils-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the surface plasmon resonance market grown over the years?

In the past few years, there has been rapid growth in the size of the surface plasmon resonance market. It’s anticipated that the market will swell from $1.19 billion in 2024 to reach $1.33 billion in 2025, marking a compound annual growth rate (CAGR) of 12.0%. This significant growth during the historic period can be credited to the advancements in biotechnology, a surge in demand for drug discovery and development, increasing utilization in clinical diagnostics, a growing focus on protein interaction research, and an upswing in academic research funding.

What Is the forecasted market size and growth rate for the surface plasmon resonance market?

The market for surface plasmon resonance is set to experience speedy expansion in the upcoming years, with projections indicating it will reach a value of $2.07 billion in 2029, and an impressive compound annual growth rate (CAGR) of 11.6%. This predicted growth during the forecast period can be ascribed to factors such as the increased need for individualized medicine, expanded application in the realm of food safety testing, intensified interest in biomarker discovery, wider usage in environmental observation, and boosted integration in the field of agricultural biotechnology. Key market trends for the forecast period entail the increased demand for no-label detection technologies, the embracement of bespoke medicine, progress in the area of nanotechnology, the evolution of portable and miniaturized SPR systems, and the amalgamation with artificial intelligence for data interpretation.

Get your surface plasmon resonance market report here!

https://www.thebusinessresearchcompany.com/report/surface-plasmon-resonance-global-market-report

What are the major factors driving growth in the surface plasmon resonance market?

The surge in embracing personalized medicine is anticipated to fuel the expansion of the surface plasmon resonance market. Personalized medicine applies a holistic approach to healthcare, utilizing individual’s genetic, environmental, and lifestyle aspects in the formulation of tailored treatment and prevention plans. This increasing use of personalized medicine is encouraged by improvements in genomics, the emergence of targeted treatments, and the demand for more accurate and efficient therapies. Surface plasmon resonance contributes to personalized medicine by facilitating real-time examination of biomolecular interactions, which aids in detecting specific biomarkers and improving drug therapies personalized to individual patients. For instance, the Personalized Medicine Coalition notified that in February 2024, a US-based hospital and healthcare organization announced that in 2023, the FDA sanctioned 16 new personalized treatments for patients with rare diseases, marking a substantial grow from 6 in 2022. Personalized treatment approvals in 2023 also included seven cancer drugs and three for other diseases and ailments. Thus, the rising endorsement of personalized medicine boosts the growth of the surface plasmon resonance market.

What key areas define the segmentation of the global surface plasmon resonance Market?

The surface plasmon resonance market covered in this report is segmented –

1) By Product Type: Imaging System, Sensor System, Reagents

2) By Technology: Prism-Based Surface Plasmon Resonance (SPR), Grating-Based Surface Plasmon Resonance (SPR), Other Technologies

3) By Application: Drug Discovery, Drug Formulation, Controlled Drug Release, Drug Cell Interaction, Material Science, Biosensors

4) By End-User: Academic And Research Institutes, Food And Beverage Industry, Biopharmaceutical Companies, Contract Research Organizations (CROs), Other End-Users

Subsegments:

1) By Imaging System: 2D Imaging Systems, 3D Imaging Systems, High-Resolution Imaging Systems

2) By Sensor System: Optical Sensor Systems, Portable Sensor Systems, Multi-channel Sensor Systems

3) By Reagents: Binding Reagents, Sample Preparation Reagents, Stabilizing Reagents

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20655&type=smp

What are the top market players propelling the growth of the surface plasmon resonance industry?

Major companies operating in the surface plasmon resonance market are GE HealthCare Technologies Inc., Sartorius AG, Cytiva, Bio-Rad Laboratories Inc., Bruker Corporation, HORIBA Ltd., Quanterix Corporation, Jubilant Biosys Limited, Quantum Design Inc., Reichert Inc., NanoSPR Devices, Creative BioMart Inc., Biocompare, Carterra Inc., NICOYA AB, Biosensing Instrument Inc., Plexera LLC, Insplorion AB, BioNavis Ltd., Affinité Instruments, IBIS Technologies B.V., Bioptix Inc

What are the key trends shaping the future of the surface plasmon resonance market?

Leading firms in the surface plasmon resonance market are advancing their biomolecular analysis technologies, such as injection technology. This will make redundant the use of several dilution series. The injection technology consolidates the process of sample dilution and injection into one, speeding up data collection in surface plasmon resonance (SPR) with fast, single-injection kinetics, and affinity measurements. For example, Sartorius AG, a pharmaceutical and laboratory equipment firm based in Germany, rolled out the Octet SF3 in April 2022. This is a cutting-edge surface plasmon resonance instrument designed for high-throughput, label-free biomolecular interaction analysis and is ideal for both regular and infrequent users due to its durable, low-maintenance build. Its groundbreaking OneStep and NeXtStep Gradient Injection technologies allow for quicker, superior quality kinetics and affinity data gathering, outstripping conventional techniques. It is specifically built to cater to the rising worldwide demand for antibody fragment characterization, vaccine research, and biologics discovery.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20655

What regions are dominating the surface plasmon resonance market growth?

North America was the largest region in the surface plasmon resonance market in 2024. The regions covered in the surface plasmon resonance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Magnetic Resonance Imaging Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/magnetic-resonance-imaging-devices-and-equipment-global-market-report

Magnetic Resonance Imaging Systems Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/magnetic-resonance-imaging-systems-devices-and-equipment-global-market-report

Magnetic Resonance Imaging Coils Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/magnetic-resonance-imaging-coils-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What are the Key Projections for the CAGR of the Surface Plasmon Resonance Market From 2025 to 2034?

Recent years have witnessed a speedy expansion of the surface plasmon resonance market size. A rise from $1.19 billion in 2024 to $1.33 billion in 2025, with a compound annual growth rate (CAGR) of 12.0%, is forecasted. This surge during the historical span is the result of multiple factors such as progressions in biotechnology, a burgeoning demand for drug discovery and development, escalating utilization in clinical diagnostic applications, heightened focus on protein interaction studies, and an upswing in academic research funding.

In the coming years, the surface plasmon resonance market is predicted to experience accelerated growth, expanding to $2.07 billion by 2029 with a compound annual growth rate (CAGR) of 11.6%. The surge anticipated in this forecast period can be credited to factors like an increased demand for custom-made medicine, the rising applicability in food safety examination, a heightened focus on the discovery of biomarkers, a wider usage in environmental supervision, and a growing acceptance in the field of agricultural biotechnology. The upcoming trends within this period are anticipated to include a rise in the demand for label-free detection technologies, an inclination towards personalized medicine, the progress in nanotechnology, the creation of mobile and reduced scale SPR systems, and a merger with artificial intelligence for analysis of data.

Which Major Market Drivers Are Expected to Boost the Surface Plasmon Resonance Market’s Growth Potential?

The growth of the surface plasmon resonance market is anticipated to be fueled by the escalating use of personalized medicine. This approach tailors healthcare based on an individual’s genetic, environmental, and lifestyle factors, providing bespoke treatment and prevention plans. The surge in the adoption of personalized medicine is primarily due to progress in genomics, the emergence of targeted therapies and the need for precise and efficient treatments. Surface plasmon resonance significantly contributes to personalized medicine by facilitating real-time analysis of biomolecular interactions, identifying specific biomarkers, and refining drug therapies to suit individual patients. For instance, stated by the Personalized Medicine Coalition, a hospital and healthcare organization based in the US, in February 2024, the FDA in 2023 sanctioned 16 novel personalized treatments for rare disease patients, improved from only 6 in 2022. These newly approved personalized treatments in 2023 included seven cancer drugs and three for various other diseases and conditions. Consequently, the growing acceptance of personalized medicine is propelling the growth of the surface plasmon resonance market.

Request Your Free Surface Plasmon Resonance Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=20655&type=smp

What Are the Key Industry Players Leading the Charge in the Surface Plasmon Resonance Market’s Growth?

Major companies operating in the surface plasmon resonance market are:

• GE HealthCare Technologies Inc.

• Sartorius AG

• Cytiva

• Bio-Rad Laboratories Inc.

• Bruker Corporation

How Are Market Trends and Shifts Impacting the Growth Trajectory of the Surface Plasmon Resonance Market?

Leading businesses in the surface plasmon resonance market are innovating and creating superior biomolecular analysis methodologies like injection technology. This advancement in technology negates the need for various dilution processes. The amalgamation of sample dilution and injection into a single procedure by injection technology simplifies the biomolecular interaction analysis, thereby speeding up data collection in surface plasmon resonance (SPR) through swift, single-injection kinetic and affinity measurements. For instance, Sartorius AG, a pharmaceutical and laboratory apparatus company based in Germany, introduced the next-gen surface plasmon resonance instrument, the Octet SF3, in April 2022. This instrument is specifically designed for high-throughput and label-free biomolecular interaction analysis. It caters to both regular and sporadic users with its sturdy and low-maternity design. The cutting-edge OneStep and NeXtStep Gradient Injection technologies incorporated in this instrument facilitate swifter and superior data collection in kinetics and affinity, clearly outstripping conventional techniques. The Octet SF3 aims to meet the rising worldwide requirements for antibody fragment characterization, vaccine research, and biologics discovery.

Get Instant Access to the Global Surface Plasmon Resonance Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/surface-plasmon-resonance-global-market-report

Which Growth-Oriented Segments of the Surface Plasmon Resonance Market Are Leading the Industry’s Development?

The surface plasmon resonance market covered in this report is segmented –

1) By Product Type: Imaging System, Sensor System, Reagents

2) By Technology: Prism-Based Surface Plasmon Resonance (SPR), Grating-Based Surface Plasmon Resonance (SPR), Other Technologies

3) By Application: Drug Discovery, Drug Formulation, Controlled Drug Release, Drug Cell Interaction, Material Science, Biosensors

4) By End-User: Academic And Research Institutes, Food And Beverage Industry, Biopharmaceutical Companies, Contract Research Organizations (CROs), Other End-Users

Subsegments:

1) By Imaging System: 2D Imaging Systems, 3D Imaging Systems, High-Resolution Imaging Systems

2) By Sensor System: Optical Sensor Systems, Portable Sensor Systems, Multi-channel Sensor Systems

3) By Reagents: Binding Reagents, Sample Preparation Reagents, Stabilizing Reagents

What Regions Are Influencing the Dynamics of the Surface Plasmon Resonance Market?

North America was the largest region in the surface plasmon resonance market in 2024. The regions covered in the surface plasmon resonance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Elements Shape the Definition of the Surface Plasmon Resonance Market?

Surface plasmon resonance (SPR) is an optical technique that measures the interaction between molecules by detecting changes in the refractive index on a sensor surface. It is widely used for real-time, label-free analysis of biomolecular interactions, such as protein-protein, protein-DNA, and antibody-antigen interactions.

Browse Through More Similar Reports By The Business Research Company:

Magnetic Resonance Imaging Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/magnetic-resonance-imaging-devices-and-equipment-global-market-report

Magnetic Resonance Imaging Systems Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/magnetic-resonance-imaging-systems-devices-and-equipment-global-market-report

Magnetic Resonance Imaging Coils Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/magnetic-resonance-imaging-coils-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: